(Q40845965)

24 September 2017

1 reference

title

Treatment of acute gastroesophageal variceal hemorrhage (English)

1 reference

24 September 2017

Brewer TG

1

1 reference

24 September 2017

publication date

1 September 1993

1 reference

Medical Clinics of North America

24 September 2017

published in

1 reference

24 September 2017

volume

77

1 reference

24 September 2017

issue

5

1 reference

24 September 2017

page(s)

993-1014

1 reference

Propranolol or endoscopic sclerotherapy in the prevention of recurrence of variceal bleeding. A prospective, randomized controlled trial

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Portal obstruction in children. I. Clinical investigation and hemorrhage risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

The natural history of esophageal varices; a study of 115 cirrhotic patients in whom varices were diagnosed prior to bleeding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Options for elective treatment of portal hypertension in cirrhotic patients in the transplantation era.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

The influence of propanolol on portosystemic shunting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Association of transdermal nitroglycerin to vasopressin infusion in the treatment of variceal hemorrhage: a placebo-controlled clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Modification of the Sengstaken-Blakemore balloon tube

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Colonic varices. A complication of pancreatitis with splenic vein thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Pitfalls in studies of prophylactic therapy for variceal bleeding in cirrhotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Randomized, double-blind, placebo-controlled trial of somatostatin for variceal bleeding. Emergency control and prevention of early variceal rebleeding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Endoscopic sclerotherapy versus portacaval shunt in patients with severe cirrhosis and acute variceal hemorrhage. Long-term follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Endoscopic Sclerotherapy versus Portacaval Shunt in Patients with Severe Cirrhosis and Variceal Hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Vasopressin and nitroglycerin in the treatment of bleeding varices: the bottom line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Sclerotherapy after first variceal hemorrhage in cirrhosis. A randomized multicenter trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Upper gastrointestinal bleeding. Nature and magnitude of the problem in the U.S.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Natural/spontaneous shunts in non-cirrhotic portal fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Influence of hepatic reserve and cause of esophageal varices on survival and rebleeding before and after the introduction of sclerotherapy: a retrospective analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Surgical treatment of portal hypertension: a historical perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Prevention of recurrent bleeding in cirrhotics with recent variceal hemorrhage: prospective, randomized comparison of propranolol and sclerotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

A randomized trial of terlipressin plus nitroglycerin vs. balloon tamponade in the control of acute variceal hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Placebo-controlled trial of terlipressin (glypressin) in the management of acute variceal bleeding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

7 January 2021

Endoscopic sclerotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Esophageal Variceal Hemorrhage: Diagnosis and an Overview of Treatment:

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Portal pressure, presence of gastroesophageal varices and variceal bleeding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Varices of the colon: diagnosis by colonoscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

National ASGE survey on upper gastrointestinal bleeding: complications of endoscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

A randomized trial of vasopressin and vasopressin plus nitroglycerin in the control of acute variceal hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Compensated cirrhosis: Natural history and prognostic factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Prospective evaluation of esophageal varices in primary biliary cirrhosis: development, natural history, and influence on survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Is sclerotherapy the treatment of choice for bleeding esophageal varices?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

The natural history of nonalcoholic cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Selective shunt in the management of variceal bleeding in the era of liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

The natural history of haemorrhage from oesophageal varices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

An 8-year prospective experience with balloon tamponade in emergency control of bleeding esophageal varices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Role of endoscopic variceal sclerotherapy in the long-term management of variceal bleeding: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Comparison of Intravenous Somatostatin and Vasopressin Infusions in Treatment of Acute Variceal Hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Hemodynamic effects of blood volume restitution following a hemorrhage in rats with portal hypertension due to cirrhosis of the liver: influence of the extent of portal-systemic shunting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Splanchnic and systemic hemodynamics in portal hypertensive rats during hemorrhage and blood volume restitution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Gastric lesions in portal hypertension: inflammatory gastritis or congestive gastropathy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Long-term follow-up study of adult patients with non-cirrhotic obstruction of the portal system: comparison with cirrhotic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Circulatory changes in chronic liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Overdistension of the gastric balloon. Complication with the Sengstaken-Blakemore tube

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Health and Medical Care in Ethiopia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Percutaneous transhepatic portal vein angioplasty and stent placement after liver transplantation: early experience.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Efficacy of balloon tamponade in treatment of bleeding gastric and esophageal varices. Results in 151 consecutive episodes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Endoscopic sclerosis and esophageal balloon tamponade in acute hemorrhage from esophagogastric varices: a prospective controlled randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Controlled trial of vasopressin and balloon tamponade in bleeding esophageal varices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Variceal sclerotherapy: the combination of thrombosclerosis and the intentional removal of the distal esophageal mucosa to treat variceal bleeding and prevent variceal recurrence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Hemodynamic factors involved in the development and rupture of esophageal varices: a pathophysiologic approach to treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Drug therapy for portal hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Somatostatin for variceal bleeders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Transjugular intrahepatic portacaval stent shunt: preliminary clinical results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Shunt surgery versus endoscopic sclerotherapy for long-term treatment of variceal bleeding. Early results of a randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Using transjugular intrahepatic portosystemic shunts to control variceal bleeding before liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Prevention of recurrent variceal bleeding in alcoholic cirrhotic patients: prospective controlled trial of propranolol and sclerotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Oesophageal varices in a region of the Sudan endemic for Schistosoma mansoni

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Endoscopic variceal ligation in patients who have failed endoscopic sclerotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Intravariceal versus paravariceal sclerotherapy: a prospective, controlled, randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Balloon tamponage for the control of hemorrhage from esophageal varices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

The national ASGE survey on upper gastrointestinal bleeding. II. Clinical prognostic factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Isoproterenol in offsetting adverse effects of vasopressin in cirrhotic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Variceal sclerotherapy: further progress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Terlipressin (triglycyl-lysine vasopressin) controls acute bleeding oesophageal varices. A double-blind, randomized, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Liver transplantation (2).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Esophageal transection with paraesophagogastric devascularizations (the Sugiura procedure) in the treatment of esophageal varices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Upper gastrointestinal bleeding in patients with esophageal varices. What is the most common source?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Source of upper gastrointestinal bleeding in patients with esophageal varices seen at endoscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Prospective controlled trial of elective endoscopic sclerotherapy in comparison with percutaneous transhepatic obliteration of esophageal varices in patients with nonalcoholic cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Sclerotherapy for bleeding esophageal varices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Sclerotherapy vs. distal splenorenal shunt in the elective treatment of variceal hemorrhage: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Controlled trial of vasopressin plus nitroglycerin vs. vasopressin alone in the treatment of bleeding esophageal varices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

A multicenter, randomized, double-blind trial of somatostatin in the management of acute hemorrhage from esophageal varices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

A new endoscopic elastic band ligating device

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Endoscopic ligation of esophageal varices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Terlipressin in bleeding esophageal varices: a placebo-controlled, double-blind study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Distal splenorenal shunt versus endoscopic sclerotherapy for long-term management of variceal bleeding. Preliminary report of a prospective, randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Selective Trans-Splenic Decompression Of Gastroesophageal Varices By Distal Splenorenal Shunt

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Controlled clinical trial of injection sclerotherapy for active variceal bleeding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Comparison of propranolol with injection sclerotherapy in prevention of rebleeding from oesophageal varices in cirrhotic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

A controlled trial of oral propranolol compared with injection sclerotherapy for the long-term management of variceal bleeding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Injection sclerotherapy for the long-term management of variceal bleeding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Liver transplantation for variceal hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Technical advances in transjugular intrahepatic portosystemic shunts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

Sengstaken-Blakemore tube for control of massive bleeding from gastric varices in hiatal hernia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Nonshunting operations for variceal hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930207-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0025-7125(16)30207-3

0 references

1 reference